[go: up one dir, main page]

DK0450345T3 - Indolderivater - Google Patents

Indolderivater

Info

Publication number
DK0450345T3
DK0450345T3 DK91103628.3T DK91103628T DK0450345T3 DK 0450345 T3 DK0450345 T3 DK 0450345T3 DK 91103628 T DK91103628 T DK 91103628T DK 0450345 T3 DK0450345 T3 DK 0450345T3
Authority
DK
Denmark
Prior art keywords
quinuclidinyl
ind
indole derivatives
indolyl
quinuclidines
Prior art date
Application number
DK91103628.3T
Other languages
English (en)
Inventor
Klaus-Otto Dr Minck
Henning Dr Boettcher
Christoph Dr Seyfried
Hans-Peter Prof Dr Wolf
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK0450345T3 publication Critical patent/DK0450345T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK91103628.3T 1990-03-24 1991-03-09 Indolderivater DK0450345T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4009565A DE4009565A1 (de) 1990-03-24 1990-03-24 Indolderivate

Publications (1)

Publication Number Publication Date
DK0450345T3 true DK0450345T3 (da) 1995-08-07

Family

ID=6403022

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91103628.3T DK0450345T3 (da) 1990-03-24 1991-03-09 Indolderivater

Country Status (15)

Country Link
US (1) US5227386A (da)
EP (1) EP0450345B1 (da)
JP (1) JPH04235184A (da)
KR (1) KR910016747A (da)
AT (1) ATE123031T1 (da)
AU (1) AU631303B2 (da)
CA (1) CA2038908A1 (da)
DE (2) DE4009565A1 (da)
DK (1) DK0450345T3 (da)
ES (1) ES2072467T3 (da)
HU (1) HU207069B (da)
IE (1) IE70661B1 (da)
PT (1) PT97100A (da)
TW (1) TW217411B (da)
ZA (1) ZA912198B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201038D0 (en) * 1992-01-16 1992-03-11 Glaxo Group Ltd Chemical compounds
SE9201478D0 (sv) * 1992-05-11 1992-05-11 Kabi Pharmacia Ab Heteroaromatic quinuclidinenes, their use and preparation
GB9314174D0 (en) * 1993-07-08 1993-08-18 American Home Prod 5-ht3-antagonists
CA2420235A1 (en) * 2000-08-21 2002-02-28 Georgetown University 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
DE10045112A1 (de) * 2000-09-11 2002-03-21 Merck Patent Gmbh Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
ATE385497T1 (de) * 2000-12-01 2008-02-15 Neurosearch As 3-substituierte quinuclidin-derivate und deren verwendung als nikotinischen agonisten
DE10121215A1 (de) 2001-04-30 2002-10-31 Merck Patent Gmbh Dihydro-imidazo[4,5-e]indol- und 7H-Pyrrolo[3,2-f]chinoxalin Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden
CA2482639A1 (en) * 2002-05-30 2003-12-11 Neurosearch A/S 3-substituted quinuclidines and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
AU611976B2 (en) * 1987-12-24 1991-06-27 John Wyeth & Brother Limited Aroyl urea and carbamic acid derivatives of azabicyclo compounds
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
AU5650890A (en) * 1989-05-24 1990-12-18 Nippon Shinyaku Co. Ltd. Indole derivatives and medicine

Also Published As

Publication number Publication date
HU910972D0 (en) 1991-10-28
TW217411B (da) 1993-12-11
ZA912198B (en) 1992-01-29
CA2038908A1 (en) 1991-09-25
HU207069B (en) 1993-03-01
DE4009565A1 (de) 1991-09-26
US5227386A (en) 1993-07-13
ES2072467T3 (es) 1995-07-16
JPH04235184A (ja) 1992-08-24
ATE123031T1 (de) 1995-06-15
AU7360991A (en) 1991-10-03
IE910963A1 (en) 1991-09-25
EP0450345A1 (de) 1991-10-09
IE70661B1 (en) 1996-12-11
EP0450345B1 (de) 1995-05-24
KR910016747A (ko) 1991-11-05
HUT57761A (en) 1991-12-30
PT97100A (pt) 1991-11-29
DE59105550D1 (de) 1995-06-29
AU631303B2 (en) 1992-11-19

Similar Documents

Publication Publication Date Title
US5151423B1 (en) Heterocyclic n-oxide derivatives of substituted benzo(5,6)cycloheptapyridines, compositions and methods of use
ES2090048T3 (es) Derivados de xantina.
DK0393936T3 (da) 3-substituerede 2-oxindolderivater som antiinflammatoriske midler
ATE109002T1 (de) Wasserlösliche antineoplastische taxolderivate.
DK275488A (da) Indolonderivater
ITMO910167A0 (it) Apparecchiatura per la correzione dell'astigmatismo mediante modellazione della superficie corneale per foto ablazione.
DE59105550D1 (de) Indolderivate.
FI931333A0 (fi) Foerfarande foer framstaellning av formoterol och liknande foereningar
FI944727L (fi) Indolijohdannaisia 5-HT1:n kaltaisina agonisteina
SE7811455L (sv) 2-imino-imidazolidin-derivat
FI893111L (fi) Benzotiazindioxidderivat.
GR75827B (da)
LV10098A (lv) Metilpiperazinazepina atvasinajumi to iegusana un lietosana
DE69129238D1 (de) Okulare hypotensive homo-prostaglandinderivate
FI930987A0 (fi) Nya prostaglandin-i2-derivat
FI895831A0 (fi) Foerfarande foer framstaellning av (d)-6-fluor-2,3-dihydro-2',5'-dioxo-spiro/4h-1-benzopyran-4,4' -imidazolin/-2-karboximidderivat.
GB2009157A (en) Salts of 2,8-Dicarboxy-4,6- Dioxo-10-propyl-4H,6H-Benzo [1,2- b:5,4-b']pyran
ES2089439T3 (es) Nuevos derivados amidicos de 1-amino-octahidro-pirido-(2,1-c)-(1,4)-oxazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE59102829D1 (de) Ergolinderivate.
SE8205849L (sv) Nya furobensazepiner, deras framstellning och anvendning
YU32691A (sh) 6-supstituisani-heksahidrobenz c,d indoli i postupak za njegovo dobijanje
IT8819640A0 (it) Derivato del bendazac e suoi sali farmaceuticamente accettabili.
RU93004949A (ru) Новые производные простагландина и*002